Towa Completes Deal For Pensa

Transaction Worth €329m Was Agreed In Late 2019

Japan’s Towa has completed its €329m deal for the Pensa Investments generics business of Spain’s Esteve.

Handshake_Spain_Japan
Japan’s Towa has completed the deal with Spain’s Esteve • Source: Shutterstock

Japan’s Towa Pharmaceutical has completed its €329m ($364m) deal to acquire the [Pensa Investments] generics business from Spain’s Esteve.

The closure of the deal, through which Pensa has now become a wholly-owned Towa subsidiary, comes just a month after...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business